Literature DB >> 12570904

[Pneumococcal vaccines: problems and solutions].

J J Gómez Marco1, M Canals Aracil, M C González Martínez, J Antona Casado, A Benito Poveda.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12570904      PMCID： PMC7681699          DOI： 10.1016/s0212-6567(03)70661-1

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  16 in total

1.  [Etiology and management evaluation of community acquired pneumonia].

Authors:  A Torres; N Soler
Journal:  Med Clin (Barc)       Date:  2001-02-10       Impact factor: 1.725

2.  Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials.

Authors:  C Cornu; D Yzèbe; P Léophonte; J Gaillat; J P Boissel; M Cucherat
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

3.  Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-04-04

4.  Nosocomial infections in Spain: results of five nationwide serial prevalence surveys (EPINE Project, 1990 to 1994). Nosocomial Infections Prevalence Study in Spain.

Authors:  J Vaqué; J Rosselló; A Trilla; V Monge; J García-Caballero; J L Arribas; P Blasco; J R Sáenz-Domínguez; I Albero; F Calbo; J Barrio; R Herruzo; C Sáenz-González; J M Arévalo
Journal:  Infect Control Hosp Epidemiol       Date:  1996-05       Impact factor: 3.254

5.  [Site of care provision, etiology and treatment of community-acquired pneumonia in Palma de Mallorca].

Authors:  C Santos de Unamuno; M A Llorente San Martín; E Carandell Jäger; M Gutiérrez García; M Riera Jaume; A Ramírez Rosales; A Pareja Bezares; A Corrales Nadal
Journal:  Med Clin (Barc)       Date:  1998-03-07       Impact factor: 1.725

6.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Authors:  S Black; H Shinefield; B Fireman; E Lewis; P Ray; J R Hansen; L Elvin; K M Ensor; J Hackell; G Siber; F Malinoski; D Madore; I Chang; R Kohberger; W Watson; R Austrian; K Edwards
Journal:  Pediatr Infect Dis J       Date:  2000-03       Impact factor: 2.129

7.  Clinical effectiveness of pneumococcal vaccine. Meta-analysis.

Authors:  B G Hutchison; A D Oxman; H S Shannon; S Lloyd; C A Altmayer; K Thomas
Journal:  Can Fam Physician       Date:  1999-10       Impact factor: 3.275

8.  Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10-06

9.  [Prospective study of 221 community acquired pneumonias followed up in an outpatient clinic. Etiology and clinical-radiological progression].

Authors:  F Javier Alvarez Gutiérrez; D del Castillo Otero; A García Fernández; B Romero Romero; J José del Rey Pérez; G Soto Campos; J Castillo Gómez
Journal:  Med Clin (Barc)       Date:  2001-02-10       Impact factor: 1.725

10.  Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials.

Authors:  R A Moore; P J Wiffen; B A Lipsky
Journal:  BMC Fam Pract       Date:  2000-10-04       Impact factor: 2.497
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.